Correlation Between HNI Corp and Regeneron Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both HNI Corp and Regeneron Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining HNI Corp and Regeneron Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between HNI Corp and Regeneron Pharmaceuticals, you can compare the effects of market volatilities on HNI Corp and Regeneron Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in HNI Corp with a short position of Regeneron Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of HNI Corp and Regeneron Pharmaceuticals.
Diversification Opportunities for HNI Corp and Regeneron Pharmaceuticals
0.15 | Correlation Coefficient |
Average diversification
The 3 months correlation between HNI and Regeneron is 0.15. Overlapping area represents the amount of risk that can be diversified away by holding HNI Corp and Regeneron Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Regeneron Pharmaceuticals and HNI Corp is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on HNI Corp are associated (or correlated) with Regeneron Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Regeneron Pharmaceuticals has no effect on the direction of HNI Corp i.e., HNI Corp and Regeneron Pharmaceuticals go up and down completely randomly.
Pair Corralation between HNI Corp and Regeneron Pharmaceuticals
Considering the 90-day investment horizon HNI Corp is expected to generate 0.86 times more return on investment than Regeneron Pharmaceuticals. However, HNI Corp is 1.16 times less risky than Regeneron Pharmaceuticals. It trades about -0.03 of its potential returns per unit of risk. Regeneron Pharmaceuticals is currently generating about -0.08 per unit of risk. If you would invest 5,150 in HNI Corp on October 26, 2024 and sell it today you would lose (67.00) from holding HNI Corp or give up 1.3% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
HNI Corp vs. Regeneron Pharmaceuticals
Performance |
Timeline |
HNI Corp |
Regeneron Pharmaceuticals |
HNI Corp and Regeneron Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with HNI Corp and Regeneron Pharmaceuticals
The main advantage of trading using opposite HNI Corp and Regeneron Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if HNI Corp position performs unexpectedly, Regeneron Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Regeneron Pharmaceuticals will offset losses from the drop in Regeneron Pharmaceuticals' long position.The idea behind HNI Corp and Regeneron Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.Regeneron Pharmaceuticals vs. Crispr Therapeutics AG | Regeneron Pharmaceuticals vs. Novo Nordisk AS | Regeneron Pharmaceuticals vs. Sarepta Therapeutics | Regeneron Pharmaceuticals vs. Intellia Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Other Complementary Tools
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Fundamental Analysis View fundamental data based on most recent published financial statements |